Introduction 

Artificial intelligence is becoming increasingly relevant across the Life Sciences industry. 

Its applications extend beyond drug discovery. AI is being explored across areas including research, clinical development, manufacturing, quality, regulatory activities and data analysis. 

The FDA reports increasing use of AI across the drug product lifecycle, including nonclinical, clinical, postmarketing and manufacturing activities.  

This creates an opportunity to connect scientific data, operational workflows and regulatory information through more intelligent digital systems. 

What Is AI in Life Sciences? 

AI in Life Sciences refers to the application of artificial intelligence and machine learning technologies to scientific, healthcare, pharmaceutical and biotechnology workflows. 

Potential applications include: 

• Scientific data analysis  

• Drug development  

• Clinical operations  

• Manufacturing  

• Quality management  

• Regulatory processes  

• Knowledge management  

• Predictive analytics  

• Decision support  

AI in Pharmaceutical Development 

AI can support different stages of the pharmaceutical development lifecycle. 

Potential areas include: 

Research — analysing complex scientific datasets. 

Development — supporting data-driven formulation and development activities. 

Clinical — helping analyse clinical and operational data. 

Manufacturing — supporting process and quality analytics. 

Post-market — analysing relevant safety and product information. 

FDA notes that AI components have appeared in drug submissions across multiple stages of the product lifecycle.  

AI in Regulatory & Quality 

Regulatory and quality operations generate large volumes of structured and unstructured information. 

AI can potentially support: 

• Document analysis  

• Information extraction  

• Regulatory intelligence  

• Quality data analysis  

• Knowledge retrieval  

• Workflow automation  

• Decision support  

However, AI used in regulated environments requires appropriate controls around context of use, data governance, documentation, performance and lifecycle management. FDA/EMA guiding principles for AI in drug development specifically emphasize these areas.  

AI in Biotechnology & Research 

Biotechnology and scientific research generate increasingly complex datasets. 

AI can help organizations explore relationships across scientific information, identify patterns and support data-driven research workflows. 

From AI Tools to Life Sciences Intelligence 

The next stage is not simply adding AI to individual applications. 

The greater opportunity is connecting intelligence across: 

Regulatory → Quality → Clinical → Manufacturing → Scientific Workflows 

This creates a more unified view of information across the Life Sciences lifecycle. 

Garvimi by SIX8 

Garvimi is SIX8’s Life & Bio Sciences Intelligence platform. 

Garvimi empowers pharma, biotech, and research organizations with unified intelligence across regulatory, quality, clinical, manufacturing, and scientific workflows. 

The broader vision is to connect these domains through a unified intelligence environment rather than treating each workflow as an isolated system. 

The Future of AI in Life Sciences 

AI will continue to evolve across Life Sciences, but meaningful adoption depends on more than algorithms. 

Organizations also need: 

• High-quality data  

• Appropriate governance  

• Clear use cases  

• Domain expertise  

• Validated workflows  

• Human oversight  

• Regulatory awareness  

The future of Life Sciences intelligence will therefore depend on bringing scientific expertise, technology, data and governance together.

Introduction 

Healthcare organizations generate information across clinical care, appointments, diagnostics, billing, patient services, facilities and administration. 

A Hospital Information System brings many of these activities into a connected digital environment. 

The World Health Organization describes health information systems as important for collecting, analysing and using health information, while hospital information systems can support clinical and internal management activities.  

What Is a Hospital Information System? 

A Hospital Information System, or HIS, is a digital system designed to manage and connect information and workflows across hospital operations. 

Depending on the system, this can include: 

• Patient management  

• Appointment scheduling  

• Electronic medical records  

• Prescriptions  

• Billing  

• Inpatient management  

• Diagnostics  

• Laboratory workflows  

• Patient engagement  

• Staff management  

• Reporting and analytics  

Key Modules of a Hospital Information System 

A connected HIS can bring multiple functions into a common digital environment. 

Patient Management 

Supports registration, patient information and related administrative workflows. 

Appointment & Scheduling 

Helps coordinate appointments and healthcare resources. 

EMR/EHR Clinical Notes 

Provides digital clinical documentation and patient information management. 

Prescriptions & Medication Management 

Supports prescription and medication-related workflows. 

Billing & Revenue Cycle Management 

Connects billing activities with relevant patient and service information. 

Diagnostics & Lab Management 

Supports diagnostic and laboratory workflows. 

Patient Portal & Engagement 

Provides digital channels for patient interaction and access to relevant information. 

Reports & Analytics 

Transforms operational and clinical data into reports and analytical views. 

Why HIS Matters 

A connected information environment can help reduce fragmentation between different hospital functions. 

WHO notes that effective health information systems support health-service management, decision-making, data use and coordination across healthcare environments.  

HIS and Interoperability 

Modern healthcare environments increasingly require systems to exchange information across applications and organizations. 

Interoperability is therefore an important consideration when evaluating healthcare technology. 

Yarrow HIS by SIX8 

Yarrow HIS is SIX8’s Healthcare Information System designed to connect clinical care, hospital operations, diagnostics, patient services and healthcare data within an integrated environment. 

Its solution architecture includes: 

• Patient Management  

• Appointment & Scheduling  

• EMR/EHR Clinical Notes  

• Prescriptions & Medication Management  

• Billing & Revenue Cycle Management  

• Inpatient & Facility Management  

• Diagnostics & Lab Management  

• AI-Powered Clinical Services  

• Patient Portal & Engagement  

• Staff & Resource Management  

• Reports & Analytics  

• Agentic AI & Health Twin  

The Future of Hospital Information Systems 

Healthcare information systems are increasingly moving toward connected data, interoperability, analytics and intelligent digital workflows. 

For healthcare organizations, the objective is not simply digitization—it is creating an environment where information can support clinical, operational and management processes more effectively. 

Explore Yarrow HIS → 

Introduction 

Quality in pharmaceuticals is built through controlled processes, documented procedures, appropriate testing and continuous oversight—not through final testing alone. 

FDA describes CGMP as a system of requirements covering the methods, facilities and controls used in pharmaceutical manufacturing, including production, processing and packing.  

For pharmaceutical organizations, quality assurance therefore connects documentation, processes, validation, risk management, investigations and regulatory expectations. 

What Is Pharmaceutical Quality Assurance? 

Pharmaceutical quality assurance is the structured approach used to ensure that quality requirements are defined, documented, implemented and maintained across relevant processes. 

It can include: 

• SOP management  

• Documentation review  

• Specifications  

• Validation  

• CAPA  

• Audits  

• Vendor qualification  

• Laboratory qualification  

• Quality records  

• Regulatory documentation  

What Is Pharmaceutical Regulatory Compliance? 

Regulatory compliance refers to meeting applicable legal, regulatory and quality requirements relevant to pharmaceutical products and activities. 

Requirements vary depending on: 

• Product  

• Market  

• Development stage  

• Manufacturing activity  

• Regulatory authority  

• Applicable guidelines and standards  

The Role of GMP 

Current Good Manufacturing Practice establishes requirements for pharmaceutical manufacturing controls. FDA notes that CGMP encompasses areas including facilities, equipment, components, production controls, laboratory controls, records and reports.  

Key Components of Pharmaceutical QA 

SOPs and Documentation 

Clear procedures and controlled documentation help establish consistent ways of performing and recording activities. 

Validation 

Validation provides documented evidence that defined processes, methods or systems can perform as intended. 

CAPA 

Corrective and Preventive Action provides a structured approach for addressing identified issues and preventing recurrence. 

Audits 

Audits can help organizations evaluate whether defined processes and controls are being followed and identify areas requiring attention. 

Quality Risk Management 

ICH Q9 establishes quality risk management as a dedicated component of the pharmaceutical quality framework.  

Quality Is a Lifecycle Activity 

Pharmaceutical quality extends across: 

Development → Testing → Manufacturing → Documentation → Release → Lifecycle Management 

ICH’s quality framework includes pharmaceutical development, quality risk management, pharmaceutical quality systems and lifecycle management among its core quality guidelines.  

How SIX8 Supports Quality & Regulatory Requirements 

SIX8 supports pharmaceutical organizations through structured quality, documentation, validation, audit preparation and regulatory support activities. 

Explore QA & Regulatory → 

Introduction 

Developing a pharmaceutical product involves much more than creating a formulation. It requires scientific evaluation, formulation decisions, analytical development, stability assessment and technical documentation across different stages of development. 

ICH Q8 specifically addresses pharmaceutical development, while related ICH quality guidelines cover stability, quality risk management, pharmaceutical quality systems and analytical procedure development.  

What Is Pharmaceutical Product Development? 

Pharmaceutical product development is the structured process of designing and refining a drug product so that its intended quality and performance characteristics can be achieved consistently. 

The process can involve: 

• Preformulation  

• Formulation development  

• Excipient selection  

• Analytical method development  

• Stability studies  

• Product characterization  

• Technical documentation  

• Technology transfer  

1. Preformulation Studies

Preformulation helps establish an understanding of the physical and chemical characteristics of the drug substance. 

Considerations can include: 

• Solubility  

• Stability  

• Compatibility  

• Particle characteristics  

• Moisture sensitivity  

• Drug–excipient compatibility  

2. Formulation Development

Formulation development focuses on combining the active ingredient with appropriate excipients and processing approaches to achieve the desired product characteristics. 

The formulation strategy depends on the dosage form, intended route of administration and characteristics of the drug substance. 

3. Excipient Selection

Excipients can influence the stability, manufacturability, release and overall performance of a formulation. 

Selection therefore needs to consider compatibility, functionality, concentration and the intended dosage form. 

4. Analytical Development

Analytical procedures help measure relevant product characteristics throughout development. 

Analytical development can support: 

• Assay  

• Impurities  

• Dissolution  

• Related substances  

• Stability-indicating testing  

FDA maintains laboratory methods and analytical resources covering drug quality attributes and method validation.  

5. Stability Studies

Stability studies help evaluate how product quality changes over time under specified conditions. 

The resulting information can support decisions around storage conditions, packaging and product shelf life. 

6. Technical Documentation

Documentation connects scientific development work with quality and regulatory requirements. 

Depending on the project, this can include: 

• Product development reports  

• Analytical documentation  

• Stability documentation  

• Specifications  

• Technical reports  

• Development history  

Pharmaceutical Development Is an Integrated Process 

The key point is that pharmaceutical development activities are interconnected. 

Preformulation → Formulation → Analytical Development → Stability → Documentation → Technology Transfer 

Each stage generates information that can influence the next. 

How SIX8 Supports Pharmaceutical R&D 

SIX8 supports pharmaceutical development through formulation, preformulation, analytical, stability and technical development activities, coordinated around project requirements. 

Explore Pharma R&D →